Upsher-Smith Laboratories acquires Proximagen - MarketLine Financial Deals

Upsher-Smith Laboratories acquires Proximagen

Upsher-Smith Laboratories acquires Proximagen - MarketLine Financial Deals
Upsher-Smith Laboratories acquires Proximagen
Published Aug 14, 2012
5 pages — Published Aug 14, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Upsher-Smith Laboratories, Inc., through its wholly-owned subsidiary USL Pharma International UK Limited, has acquired the entire issued share capital of Proximagen Group plc (Proximagen Neuroscience plc).

  
Source:
Document ID
MA113032_120615
Country
Country
Ticker
PRX=GB
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Upsher-Smith Laboratories acquires Proximagen" Aug 14, 2012. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Upsher-Smith-Laboratories-acquires-Proximagen-2052-82900>
  
APA:
MarketLine Financial Deals. (2012). Upsher-Smith Laboratories acquires Proximagen Aug 14, 2012. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Upsher-Smith-Laboratories-acquires-Proximagen-2052-82900>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.